KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Free Cash Flow (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Free Cash Flow data on record, last reported at $442.6 million in Q4 2025.

  • For Q4 2025, Free Cash Flow fell 2.68% year-over-year to $442.6 million; the TTM value through Dec 2025 reached $1.5 billion, up 13.66%, while the annual FY2025 figure was $1.5 billion, 13.66% up from the prior year.
  • Free Cash Flow reached $442.6 million in Q4 2025 per ZBH's latest filing, up from $363.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $525.6 million in Q4 2023 and bottomed at $172.9 million in Q1 2024.
  • Average Free Cash Flow over 5 years is $324.4 million, with a median of $322.4 million recorded in 2024.
  • The widest YoY moves for Free Cash Flow: up 649.3% in 2021, down 51.86% in 2021.
  • A 5-year view of Free Cash Flow shows it stood at $288.4 million in 2021, then tumbled by 37.31% to $180.8 million in 2022, then surged by 190.71% to $525.6 million in 2023, then fell by 13.47% to $454.8 million in 2024, then fell by 2.68% to $442.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $442.6 million in Q4 2025, $363.7 million in Q3 2025, and $328.1 million in Q2 2025.